BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12878590)

  • 1. Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated pro-MMP-2 activation and collagenolysis.
    Jiang A; Pei D
    J Biol Chem; 2003 Oct; 278(40):38765-71. PubMed ID: 12878590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
    Wang P; Nie J; Pei D
    J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
    Miyamori H; Takino T; Kobayashi Y; Tokai H; Itoh Y; Seiki M; Sato H
    J Biol Chem; 2001 Jul; 276(30):28204-11. PubMed ID: 11382769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
    Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
    J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing.
    Osenkowski P; Meroueh SO; Pavel D; Mobashery S; Fridman R
    J Biol Chem; 2005 Jul; 280(28):26160-8. PubMed ID: 15901740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
    Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
    Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2.
    Karagiannis ED; Popel AS
    J Biol Chem; 2004 Sep; 279(37):39105-14. PubMed ID: 15252025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
    Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
    Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features.
    Lang R; Braun M; Sounni NE; Noel A; Frankenne F; Foidart JM; Bode W; Maskos K
    J Mol Biol; 2004 Feb; 336(1):213-25. PubMed ID: 14741217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M; Miyamori H; Yamashita J; Sato H
    Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases.
    Kridel SJ; Sawai H; Ratnikov BI; Chen EI; Li W; Godzik A; Strongin AY; Smith JW
    J Biol Chem; 2002 Jun; 277(26):23788-93. PubMed ID: 11959855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
    Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
    J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells.
    Rozanov DV; Hahn-Dantona E; Strickland DK; Strongin AY
    J Biol Chem; 2004 Feb; 279(6):4260-8. PubMed ID: 14645246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities.
    Tam EM; Moore TR; Butler GS; Overall CM
    J Biol Chem; 2004 Oct; 279(41):43336-44. PubMed ID: 15292230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
    Lehti K; Valtanen H; Wickström SA; Lohi J; Keski-Oja J
    J Biol Chem; 2000 May; 275(20):15006-13. PubMed ID: 10748199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
    Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
    FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H; Essers L; Ulbrich N; Will H
    Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.
    Lehti K; Lohi J; Juntunen MM; Pei D; Keski-Oja J
    J Biol Chem; 2002 Mar; 277(10):8440-8. PubMed ID: 11779859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.